201,526 Shares of Perrigo Company plc $PRGO Acquired by Range Financial Group LLC

Range Financial Group LLC acquired a new position in shares of Perrigo Company plc (NYSE:PRGO) during the 3rd quarter, Holdings Channel reports. The fund acquired 201,526 shares of the company’s stock, valued at approximately $2,975,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Nisa Investment Advisors LLC boosted its stake in Perrigo by 328.8% during the third quarter. Nisa Investment Advisors LLC now owns 57,190 shares of the company’s stock worth $844,000 after buying an additional 43,854 shares during the period. Abel Hall LLC grew its holdings in shares of Perrigo by 14.0% in the third quarter. Abel Hall LLC now owns 14,630 shares of the company’s stock worth $216,000 after purchasing an additional 1,797 shares during the last quarter. SteelPeak Wealth LLC increased its stake in Perrigo by 20.8% in the 3rd quarter. SteelPeak Wealth LLC now owns 22,369 shares of the company’s stock worth $330,000 after buying an additional 3,853 shares during the period. TD Waterhouse Canada Inc. purchased a new position in Perrigo in the 3rd quarter worth about $1,621,000. Finally, Daytona Street Capital LLC lifted its holdings in Perrigo by 16.7% during the 3rd quarter. Daytona Street Capital LLC now owns 35,000 shares of the company’s stock valued at $503,000 after buying an additional 5,000 shares in the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Perrigo Price Performance

Shares of PRGO stock opened at $16.17 on Wednesday. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $22.02. The stock has a market capitalization of $2.24 billion, a price-to-earnings ratio of -1.29, a P/E/G ratio of 1.84 and a beta of 0.69. The stock has a fifty day simple moving average of $14.41 and a two-hundred day simple moving average of $12.16. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.11. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The business’s revenue was down 3.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.06) EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, analysts predict that Perrigo Company plc will post 2.18 EPS for the current fiscal year.

Perrigo Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 7.2%. The ex-dividend date was Friday, August 28th. Perrigo’s dividend payout ratio is presently -9.27%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PRGO. Weiss Ratings upgraded shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. Wall Street Zen downgraded shares of Perrigo from a “strong-buy” rating to a “buy” rating in a research note on Sunday, September 27th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $19.33.

Perrigo Profile

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.